Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TICA 2 study of intensive blood pressure control in acute ischemic stroke
2015-005776-24Phase 3Completed
- Sponsor
- Dr. Manuel RodrÃguez Yáñez
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of labetalol, urapidil and sodium nitroprusside in ischemic stroke (2 arms), sponsored by Dr. Manuel RodrÃguez Yáñez. Primary endpoint: Functional prognosis. Started Mar 2016; status: completed.
02
Drugs
labetalolurapidilsodium nitroprusside
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2015-005776-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005776-24.